10X Genomics Inc (TXG) — Financial Flexibility Index
10X Genomics Inc (TXG) has a Financial Flexibility Index of 0.09x as of June 2026. Free cash flow of $18.56 Million (operating CF $16.97 Million minus capex $1.59 Million) represents 0% of total liabilities ($204.52 Million). Check cash flow reinvestment rate of 10X Genomics Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
10X Genomics Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for 10X Genomics Inc across 9 annual periods. For the full cash flow conversion analysis, see TXG cash generation efficiency.
Annual Financial Flexibility Index for 10X Genomics Inc (2017–2025)
Year-by-year free cash flow to debt coverage for 10X Genomics Inc. Explore 10X Genomics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.58x | $141.99 Million | $136.05 Million | $245.04 Million | ▲ +534.0% |
| 2024 | 0.09x | $19.06 Million | $6.66 Million | $208.50 Million | ▼ -40.3% |
| 2023 | 0.15x | $34.33 Million | $-15.20 Million | $224.10 Million | ▼ -65.1% |
| 2022 | 0.44x | $98.06 Million | $-33.61 Million | $223.24 Million | ▲ +10.6% |
| 2021 | 0.40x | $79.91 Million | $-21.37 Million | $201.26 Million | ▲ +142.1% |
| 2020 | -0.94x | $-179.50 Million | $-217.90 Million | $190.27 Million | ▼ -326.5% |
| 2019 | 0.42x | $77.39 Million | $34.63 Million | $185.84 Million | ▲ +305.7% |
| 2018 | -0.20x | $-69.70 Million | $-76.41 Million | $344.30 Million | ▼ -448.5% |
| 2017 | -0.04x | $-6.94 Million | $-10.70 Million | $188.12 Million | — |